GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, sales@genprice.com

Index / Trevigen / Cultrex Human BME PathClear / Product Detail : 3415-001-02 Cultrex Human BME PathClear
Related keywords:

Jul
26th

#3415-001-02 Cultrex Human BME PathClear

Ask technical file .

  Price : 282   EUR
320   USD
219   GBP
1186   Zloty
37788   JPY
2178   NOK
2333   SEK
319   CHF

Product name : Cultrex Human BME PathClear

Catalog number : 3415-001-02

Quantity: 1 mg/ 1ml

Availability: Yes

Supplier name : Trevigen

ask pdf gentaur products Data sheet: Ask more or other datasheet now !

About this Product :

Cultrex Human BME PathClear Human samples 80 % of the research is conducted on human samples. GENTAUR suppliers human normal cells, cell lines, RNA extracts and lots of antibodies and ELISA kits to Human proteins as well as Cultrex Human BME PathClear.
http://mybiofast.com/ver.php?search=human+&submit=Search

More Details about

Cultrex® Human BME *PathClear®


Size: 1 ml


Description: Basement membranes are continuous sheets of specialized extracellular matrix that form an interface between endothelial, epithelial, muscle, or neuronal cells and their adjacent stroma. Basement membranes are degraded and regenerated during development and wound repair. They not only support cells and cell layers, but they also play an essential role in tissue organization that affects cell adhesion, migration, proliferation, and differentiation. Basement membranes provide major barriers to invasion by metastatic tumor cells. Cultrex® Human Basement Membrane Extract (BME) is a soluble form of basement membrane purified from human placenta. BME can be used for promotion and maintenance of an undifferentiated phenotype, or differentiation of precursors, including stem cells, into primary epithelial cells, endothelial cells and smooth muscle cells. It has been employed in cell attachment assays, neurite outgrowth assays, and tumor cell invasion assays.


Specifications:


Concentration: 1 mg/ml


Source: Human Placenta


Storage Buffer: Dulbecco’s Modified Eagle’s medium containing 10 μg/ml gentamycin sulfate and no phenol red.


Storage/Stability: Product is stable for a minimum of 3 months from date of shipment when stored at –80 °C. Repeated freeze-thaws will destroy product integrity.


Material Qualification:


Functional Assay:
· Human BME promotes attachment of human osteosarcoma MG63 cells.


*Sterility Testing:


· No bacterial or fungal growth detected after incubation at 37 °C for 14 days
· No mycoplasma contamination detected by PCR.
· Human BME has tested negative for eight human pathogenic viruses including Hepatitis A, B and C, HIV 1 and 2, Hantaan, Seoul, and Sin Nombre by PCR.
· Endotoxin concentrations ≤ 20 EU/ml by LAL assay.


Safety Statement:


Cultrex® Human BME *PathClear® contains human source material and therefore should be treated as potentially infectious and handled at the Biological Safety Level 2 to minimize exposure.

Coating Procedures:


1. Thaw Human BME at 4oC or on ice.
2. Mix BME by pipetting solution up and down.
3. Dilute BME to desired concentration in cold serum-free medium. Empirical determination of the optimal coating concentration for your application may be required. A protein concentration 150 μg/ml is a recommended starting concentration for the propagation of primary cells.
4. Add a sufficient amount of solution to cover the entire area onto growth surface. A volume of 250 μl per cm2 is recommended.
5. Place coated object at 37 °C, and 5% CO2 for a minimum of 2 hours or as long as overnight.
6. Aspirate coating medium.
7. Coated objects are ready for use.


References:


1. Albini, A., Y. Iwamoto, H. Kleinman, G. Martin, S. Aaronson, J. Kozlowski, and R. McEwan. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239-3245.
2. Fridman, R., G. Giaccone, T. Kanemoto, G. Martin, A. Gazdar, and J. Mulshine. 1990. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc. Natl. Acad. Sci. USA 87:6698-6702.
3. Fridman, R., M. Kibbey, L.. Royce, M. Zain, T. Sweeney, D. Jicha, J. Yannelli, G. Martin, and H. Kleinman. 1991. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with matrigel. J. Natl. Cancer Inst. 83:769-774.
4. Fridman, R., T. Sweeney, M. Zain, G. Martin, and H. Kleinman. 1992. Malignant transformation of NIH-3T3 cells after subcutaneous co-injection with a reconstituted basement membrane (matrigel). Int. J. Cancer 51:740-744.
5. Kubota, Y., H. Kleinman, G. Martin, and T. Lawley. 1988. Role of laminin and basement membrane proteins in the morphological differentiation of human endothelial cells in capillary-like structures. J. Cell Biol. 107:1589-1598.
6. Ponce, M., M. Nomizu, M. Delgado, Y. Kuratomi, M. Hoffman, S. Powell, Y. Yamada, H. Kleinman, and K. Malinda. 1999. Identification of endothelial cell binding sites on the laminin

Contact us about this product :

Our team will respond you as soon as possible !

Email :
Skype :
Name :
Phone :
address :
Question, Comment ... :
arrow security gentaurPlease retype this code below:
Trevigen \ Cultrex_Human_BME_PathClear \ 3415_001_02
Reload Image

 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur